Fact CheckerSign in

NCT07506161Completed

Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

Thermoablation Treatment of Malignant Thyroid Carcinomas

Source: ClinicalTrials.gov · Last updated 9 Jun 2026

Brief summary (registry, in English)

Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.

Status (registry)
Completed
Study type
Observational
Enrollment
27 (actual)
First submitted
13 Mar 2026
Start date
9 Sept 2021
Primary completion date
31 Dec 2025
Lead sponsor
Premier G Med Cardio Kft
NCT number
NCT07506161

What you commit to

  • Study type: Observational
  • Participants enrolled: 27
  • From 9 Sept 2021 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of or active disease: neck irradiation, stroke, CV disease, CNS vascular malformation, any malignant disease, immunocompromised state, recurrent laryngeal nerve paresis, organ failure

Lab values

  • calcitonin or serum calcium over the threshold on a repeat blood test

Other

  • extrathyroidal extension of tumor (including capsular)
  • pregnancy
  • lesion less than 5 mm close to the danger zone
  • safety margin could not be obtained (min 2mm)
  • uncontrolled hyperthyroidism
  • uncontrolled hypothyroidism
  • primary hyperparathyroidism

Who the study is looking for

  • Adult patients with cytologically confirmed papillary thyroid carcinoma with the longest diameter of less than or equal to 10 mms in T1aN0M0 clinical stage without metastases and without cytological signs of aggressivity AND
  • Patients objecting to both surgery and active surveillance

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Premier Med Egészségügyi- Oktató- és Kutatóintézet
Coordinator of this site? Confirm its status
BudapestHungaryUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.